Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Schizophrenia

  Free Subscription


23.03.2026

4 Biol Psychiatry
2 Mol Psychiatry
4 PLoS One
5 Psychiatry Res
8 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Biol Psychiatry

  1. XIAO Y, Li M, Liao J, Yan J, et al
    CINP: a causality-informed framework for generalizable and replicable neuroimaging prediction of antipsychotic response in schizophrenia.
    Biol Psychiatry. 2026 Mar 13:S0006-3223(26)01103.
    PubMed         Abstract available

  2. XU B, Dijkzeul A, Zhang Y, Schuurmans IK, et al
    Genetic susceptibility to schizophrenia and the onset of brain developmental change in adolescence.
    Biol Psychiatry. 2026 Mar 13:S0006-3223(26)01104.
    PubMed         Abstract available

  3. CHOPRA S
    Variability Is the Norm in Magnetic Resonance Imaging of Psychosis.
    Biol Psychiatry. 2026;99:515-516.
    PubMed        

  4. ZHANG D, Wang J
    Successful Nonpharmacological Treatment Strategy for Cognitive Impairment in Individuals With Schizophrenia.
    Biol Psychiatry. 2026;99:511-512.
    PubMed        


    Mol Psychiatry

  5. SEUFFERT S, Mulfarth RR, Teutenberg L, Thomas-Odenthal F, et al
    Linking speech patterns to brain structure in affective and psychotic disorders: an integrative natural language processing approach.
    Mol Psychiatry. 2026;31:2057-2068.
    PubMed         Abstract available

  6. LI Q, Liu J, Pearlson GD, Chen J, et al
    Spatiotemporal complexity in the psychotic brain.
    Mol Psychiatry. 2026;31:2014-2028.
    PubMed         Abstract available


    PLoS One

  7. FIVEL L, Lavandier M, Grimault N, Perrin F, et al
    Is it inside my head? Characterization of sound externalization in schizophrenia.
    PLoS One. 2026;21:e0345074.
    PubMed         Abstract available


  8. Expression of Concern: Schizophrenia as a Network Disease: Disruption of Emergent Brain Function in Patients with Auditory Hallucinations.
    PLoS One. 2026;21:e0345144.
    PubMed        

  9. MASUMO Y, Kanahara N, Otsuka Y, Sudo Y, et al
    Neural substrates of treatment-resistant schizophrenia and the response to clozapine: A structural MRI study in a clinical setting.
    PLoS One. 2026;21:e0345078.
    PubMed         Abstract available

  10. HOSSAIN MM, Tawhid MNA
    Exploring brain lobe-specific insights in an explainable framework for EEG-based schizophrenia detection.
    PLoS One. 2026;21:e0334389.
    PubMed         Abstract available


    Psychiatry Res

  11. MOU L, Gong B, Tan Q, Wang H, et al
    Classification of functional near-infrared spectroscopy (fNIRS) signals in schizophrenia and bipolar disorder using deep learning methods.
    Psychiatry Res. 2026;360:117084.
    PubMed         Abstract available

  12. CORRELL CU, Yildirim M, Zhang Z, Palma AM, et al
    Efficacy and safety of brexpiprazole in early-episode schizophrenia: post hoc analysis of Phase 3 clinical trials in adults and adolescents.
    Psychiatry Res. 2026;360:117091.
    PubMed         Abstract available

  13. LI YW, Yeh TC, Chien WC, Chung CH, et al
    Role of depression and anxiety in the treatment modalities and age-stratified dementia risk in patients with schizophrenia, a real-world nationwide cohort study.
    Psychiatry Res. 2026;360:117061.
    PubMed         Abstract available

  14. GOH KK, Chen PY, Chang HM, Kanahara N, et al
    Longitudinal associations among childhood trauma, oxytocin, and metabolic risk in schizophrenia.
    Psychiatry Res. 2026;360:117088.
    PubMed         Abstract available

  15. SEDEF MM, Oruc EB, Bulut SD, Hatil SI, et al
    Zonulin as an endophenotype for schizophrenia: A study in patients and unaffected siblings.
    Psychiatry Res. 2026;360:117102.
    PubMed         Abstract available


    Schizophr Res

  16. ZHAO C, Lin B, Naderi E, Moazzen S, et al
    Genetic susceptibility of cardiometabolic outcomes in schizophrenia spectrum disorders.
    Schizophr Res. 2026;292:103-115.
    PubMed         Abstract available

  17. NAGENDRA A, Mesholam-Gately R, Shafrin J, Keshavan MS, et al
    Reframing schizophrenia as a neurodevelopmental syndrome: The scientific and social imperative.
    Schizophr Res. 2026;292:96-102.
    PubMed         Abstract available

  18. TANG JY, Wong GH, Zhou H, Zhou J, et al
    Ten-year risk prediction models for atherosclerotic cardiovascular disease in Chinese patients with schizophrenia-spectrum disorders: A population-based cohort study.
    Schizophr Res. 2026;292:88-95.
    PubMed         Abstract available

  19. CANO JF, Galindo-Pita S, Mendez D, Vallejo-Silva A, et al
    Association between Toxoplasma gondii IgG seropositivity and schizophrenia: A case-control study in Colombia.
    Schizophr Res. 2026;292:79-87.
    PubMed         Abstract available

  20. SABE M, Grof P, Sackett NB, Tai S, et al
    Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review.
    Schizophr Res. 2026;292:69-78.
    PubMed         Abstract available

  21. TARGUM SD, Watson C, Claxton A, Nicolas P, et al
    Low incidence of extrapyramidal symptoms following treatment with a muscarinic agonist medication for schizophrenia.
    Schizophr Res. 2026;292:53-59.
    PubMed         Abstract available

  22. SHEPHERD R, Stacey D, Janetzki J, Clark SR, et al
    Disentangling the relationship between psychiatric disorders, cardiometabolic abnormalities, and antipsychotics: A systematic review of genomic studies.
    Schizophr Res. 2026;291:119-134.
    PubMed         Abstract available

  23. DAZZAN P, Shivakumar G, Szymaniak K, Bell E, et al
    Restoring scientific resilience through European collaboration.
    Schizophr Res. 2026;290:30-33.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum